sibrotuzumab
nitroprotein
granulocytic leukemia
granulocyte-macrophage colony-stimulating factor
adecatumumab
mesothelioma
muskelin
hyperproteinemia
angiostatin
CD40
adenosarcoma
endotheliotropic
mesotrypsinogen
Matrigel
angiomotin
mesentoblast
dulanermin
neostatin
oncotropic
multiple myeloma
taplitumomab
chondroblast
evolocumab
blinatumomab
fiber
fibre
neoplastic cell
lophocyte
drozitumab
intrabody
carfilzomib
thrombomodulin
oleclumab
paraprotein
hepatocarcinogenetic
tuberous sclerosis
mesenchymogenic
fibropellin
cytoalbuminologic
robatumumab
tuberin
properdin
panitumumab
siltuximab
indatuximab ravtansine
onartuzumab
complementology
necitumumab
lucatumumab
merlin